The examples of reduced TRAIL receptor include loss of DR4 expression in lung squamous cell carcinoma (86) and reduced DR4 and DR5 expression in hepatocellular carcinoma (HCC), which correlated with shorter overall 5-year survival of patients (87). This evidence concerns the gene TNFRSF10A and squamous cell lung carcinoma.